Skip to content

Medicalisation of Ayahuasca as a Depression Treatment

Elena Gomel Cordeiro

The Maastricht Journal of Liberal Arts September 19, 2023 DOI: 10.26481/mjla.2023.v14.912 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Topics Ayahuasca Depression
Keywords Indigenous Biomedicine Medicalization Depression economics Western medicine Traditional medicine Alternative medicine Anthropology Ecology Traditional chinese medicine
Key points Argues that medicalizing ayahuasca creates an unjustified hierarchy of scientific knowledge over indigenous knowledge systems, potentially harming treatment effectiveness.

Abstract

This paper examines the possible consequences of medicalising the psychedelic Ayahuasca to be used as a treatment for depression. Through a science and technology studies (STS) understanding of the social construction of scientific facts, I consider how traditional indigenous uses of Ayahuasca are translated into Western medicine. Two special points of attention are: (1) the cultural reductivism entailed in the standardisation of the active substance of Ayahuasca (DMT), understood through Martin’s (2000) analysis of neuroreductivism in Western medicine, and (2) the issue of biopiracy, wherein biological resources are appropriated without fair compensation for indigenous communities. In conclusion, I suggest that the dangers of medicalising ayahuasca boil down to an unjustified hierarchy of scientific knowledge over indigenous knowledge systems, which might lead to serious consequences also for the effectiveness of the proposed treatment. Keywords: Medicalization, Ayahuasca, Neuroreductivism, Biopiracy

Comparable studies

Other theoretical and historical papers on ayahuasca, most cited first.

Explore topics

By condition and practice